Evidence map›Paper›PMID 33967269›Full record

ArticleLeukemia2021

Tip60 activates Hoxa9 and Meis1 expression through acetylation of H2A.Z, promoting MLL-AF10 and MLL-ENL acute myeloid leukemia.

Kazutsune Yamagata, Mika Shino, Yukiko Aikawa, Shuhei Fujita, Issay Kitabayashi

Abstract read
PubMed Publisher
In one paragraph

Article in Leukemia, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 20 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. HOXA9 Regulome and Pharmacological Interventions in Leukemia.Advances in experimental medicine and biology · 2024
    Review
  10. Article
  11. Article
  12. Review
  13. PGEProceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Kazutsune YamagataDivision of Hematological Malignancy, National Cancer Center Research Institute, Chuo-ku, Tokyo, Japan.
Mika ShinoDivision of Hematological Malignancy, National Cancer Center Research Institute, Chuo-ku, Tokyo, Japan.
Yukiko AikawaDivision of Hematological Malignancy, National Cancer Center Research Institute, Chuo-ku, Tokyo, Japan.
Shuhei FujitaDivision of Hematological Malignancy, National Cancer Center Research Institute, Chuo-ku, Tokyo, Japan.
Issay KitabayashiDivision of Hematological Malignancy, National Cancer Center Research Institute, Chuo-ku, Tokyo, Japan. ikitabay@ncc.go.jp.ORCID http://orcid.org/0000-0002-8409-0407
National Cancer Research Institute · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chromosome translocations involving the MLL gene are common rearrangements in leukemia. Such translocations fuse the MLL 5'-region to partner genes in frame, producing MLL-fusions that cause MLL-related leukemia. MLL-fusions activate transcription of target genes such as HoxA cluster and Meis1, but the underlying mechanisms remain to be fully elucidated. In this study, we discovered that Tip60, a MYST-type histone acetyltransferase, was required for the expression of HoxA cluster and Meis1 genes and the development of MLL-fusion leukemia. Tip60 was recruited by MLL-AF10 and MLL-ENL fusions to the Hoxa9 locus, where it acetylated H2A.Z, thereby promoting Hoxa9 gene expression. Conditional deletion of Tip60 prevented the development of MLL-AF10 and MLL-ENL leukemia, indicating that Tip60 is indispensable for the leukemogenic activity of the MLL-AF10 and MLL-ENL-fusions. Our findings provide novel insight about epigenetic regulation in the development of MLL-AF10 and MLL-ENL-fusion leukemia.

Indexed as

AcetylationAnimalsEpigenesis, GeneticGene Expression Regulation, LeukemicGene RearrangementHistonesHomeodomain ProteinsHumansLeukemia, Myeloid, AcuteLysine Acetyltransferase 5MiceMyeloid Ecotropic Viral Integration Site 1 ProteinMyeloid-Lymphoid Leukemia ProteinOncogene Proteins, FusionTranslocation, GeneticHistoneshomeobox protein HOXA9Homeodomain ProteinsKAT5 protein, humanLysine Acetyltransferase 5MEIS1 protein, humanMLL-AF10 fusion protein, humanMLL-ENL oncoprotein, humanMyeloid Ecotropic Viral Integration Site 1 ProteinMyeloid-Lymphoid Leukemia ProteinOncogene Proteins, Fusion

Identifiers

PMID33967269
OpenAlexW3160661629

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.